Matthew S. Loewenstein

759 total citations
25 papers, 573 citations indexed

About

Matthew S. Loewenstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Matthew S. Loewenstein has authored 25 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Matthew S. Loewenstein's work include Radiopharmaceutical Chemistry and Applications (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Matthew S. Loewenstein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Matthew S. Loewenstein collaborates with scholars based in United States, Taiwan and Germany. Matthew S. Loewenstein's co-authors include Norman Zamcheck, Leonard I. Kleinman, Gerd Plewig, Michael B. Gregg, Martin Schaller, K. Jacob, W Burgdorf, Michael Vogeser, Leo Kaufman and Léon Goldstein and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Matthew S. Loewenstein

25 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew S. Loewenstein United States 12 180 146 110 102 100 25 573
R. Stenger France 15 178 1.0× 101 0.7× 144 1.3× 124 1.2× 90 0.9× 37 651
J. Gordon Canada 14 66 0.4× 102 0.7× 75 0.7× 140 1.4× 105 1.1× 28 841
Mervin Silverberg United States 18 73 0.4× 171 1.2× 137 1.2× 92 0.9× 261 2.6× 35 753
Jon Lamvik Norway 15 160 0.9× 134 0.9× 51 0.5× 247 2.4× 66 0.7× 58 877
A. Georgii Germany 12 142 0.8× 208 1.4× 72 0.7× 223 2.2× 78 0.8× 87 872
Miriam L. Christ United States 13 108 0.6× 158 1.1× 117 1.1× 199 2.0× 235 2.4× 19 765
G T Williams United Kingdom 8 259 1.4× 190 1.3× 75 0.7× 263 2.6× 257 2.6× 11 941
John T. Prior United States 15 122 0.7× 172 1.2× 155 1.4× 71 0.7× 181 1.8× 43 748
D. L. Barnard United Kingdom 15 120 0.7× 157 1.1× 87 0.8× 103 1.0× 46 0.5× 31 657
J. Rothwell United Kingdom 15 135 0.8× 220 1.5× 151 1.4× 112 1.1× 319 3.2× 21 831

Countries citing papers authored by Matthew S. Loewenstein

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Loewenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Loewenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Loewenstein more than expected).

Fields of papers citing papers by Matthew S. Loewenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Loewenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Loewenstein. The network helps show where Matthew S. Loewenstein may publish in the future.

Co-authorship network of co-authors of Matthew S. Loewenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Loewenstein. A scholar is included among the top collaborators of Matthew S. Loewenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Loewenstein. Matthew S. Loewenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaller, Martin, Matthew S. Loewenstein, Claudia Borelli, et al.. (2005). Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. British Journal of Dermatology. 153(1). 66–71. 85 indexed citations
2.
Scapa, Eitan, B. H. Novis, Matthew S. Loewenstein, Peter Thomas, & Norman Zamcheck. (1988). Serum ?-N-acetyl hexosaminidase and bile acid levels in patients with benign and malignant biliary obstruction. Digestive Diseases and Sciences. 33(2). 189–192. 7 indexed citations
3.
Scapa, Eitan, Peter Thomas, Matthew S. Loewenstein, & Norman Zamcheck. (1985). Serum β-N-acetyl hexosaminidase (β-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: Comparison with carcinoembryonic antigen (CEA). European Journal of Cancer and Clinical Oncology. 21(9). 1037–1042. 11 indexed citations
4.
Scapa, Eitan, et al.. (1985). Differences in CEA Values Determined by EIA and RIA in Patients with Benign and Malignant Biliary Obstructions. American Journal of Clinical Pathology. 83(5). 589–593. 4 indexed citations
5.
Loewenstein, Matthew S., et al.. (1982). Circulating CEA levels in patients with fulminant hepatitis. Digestive Diseases and Sciences. 27(2). 139–142. 16 indexed citations
6.
Loewenstein, Matthew S., et al.. (1980). Duodenal Carcinoembryonic Antigen in Patients With Benign and Malignant Diseases: Preliminary Observations23. JNCI Journal of the National Cancer Institute. 64(2). 235–240. 7 indexed citations
7.
Loewenstein, Matthew S. & Norman Zamcheck. (1978). Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer. 42(S3). 1412–1418. 100 indexed citations
9.
Gardner, Richard C., et al.. (1978). Serial carcinoembryonic antigen (CEA) blood levels in patients with ulcerative colitis. Digestive Diseases and Sciences. 23(2). 129–133. 23 indexed citations
10.
Loewenstein, Matthew S., et al.. (1978). Carcinoembryonic Antigen Assay of Ascites and Detection of Malignancy. Annals of Internal Medicine. 88(5). 635–638. 46 indexed citations
11.
Loewenstein, Matthew S. & Norman Zamcheck. (1977). Carcinoembryonic Antigen and the Liver. Gastroenterology. 72(1). 161–166. 44 indexed citations
12.
Loewenstein, Matthew S., Herbert Z. Kupchik, & Norman Zamcheck. (1976). Disparity between CEA-Roche “Indirect” and “Direct” Carcinoembryonic Antigen Values: Clinical Relevance. New England Journal of Medicine. 294(20). 1123–1123. 15 indexed citations
13.
Sharma, Meenu, James A. Gregg, Matthew S. Loewenstein, Richard P. McCabe, & Norman Zamcheck. (1976). Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. Cancer. 38(6). 2457–2461. 29 indexed citations
14.
Gregg, Michael B., et al.. (1973). Outbreak of histoplasmosis associated with the 1970 earth day activities. The American Journal of Medicine. 54(3). 333–342. 61 indexed citations
15.
Loewenstein, Matthew S., et al.. (1972). Shigellosis in the United States, 1970. The Journal of Infectious Diseases. 125(4). 441–443. 4 indexed citations
16.
Loewenstein, Matthew S.. (1972). Epidemiology ofClostridium perfringensFood Poisoning. New England Journal of Medicine. 286(19). 1026–1028. 10 indexed citations
17.
Fox, M.D., Matthew S. Loewenstein, & S. M. Martin. (1972). Salmonella Surveillance--1970. The Journal of Infectious Diseases. 125(2). 196–198. 9 indexed citations
18.
Loewenstein, Matthew S., et al.. (1972). SHIGELLA SONNEI OUTBREAK ON THE ISLAND OF MAUI. American Journal of Epidemiology. 96(1). 50–58. 3 indexed citations
19.
Loewenstein, Matthew S., et al.. (1971). Surveillance for Salmonella-1969. The Journal of Infectious Diseases. 123(3). 332–334. 9 indexed citations
20.
Loewenstein, Matthew S., Steven H. Lamm, Eugene J. Gangarosa, & H. W. Anderson. (1971). Salmonellosis Associated with Turtles. The Journal of Infectious Diseases. 124(4). 433–433. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026